Inhibitor of Normal Growth (ING)
Inhibitor of Normal Growth (ING)
批准号:
7733297
负责人:
Curtis Harris
金额:
$64.86万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ApoptosisBindingCell AgingCodeConditionDouble MinutesFamilyFibroblastsGenesGoalsGrowthGrowth InhibitorsHumanMediatingMicroRNAsMusPhenotypePhysiologicalProcessProtein FamilyProteinsRNA SplicingRegulationSignal TransductionSmall Interfering RNAStressTP53 geneVariantcell growthcell growth regulationcell motilityinhibitor/antagonistinterestpromotersenescence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nutlin-3a, an inhibitor of murine double minute 2(MDM2), has the ability to activate p53, leading to p53-regulated processes such as apoptosis and cell growth arrest. We found that premature cellular senescence was a phenotype induced by Nutlin-3a-mediated activation of endogenouse p53 functions in normal human fibroblasts. The miR-34 families of microRNAs (miR-34a, miR-34b and miR-34c) were upregulated with the Nutlin-3a-induced senescence in a p53-dependent manner, suggesting the physiological importance of the endogenously expressed miR-34 family in the regulation of cellular senescence. Among the protein-coding genes which were altered in expression by Nutlin-3a, we selected ING2 for further study; a gene we studied previously. p53 directly bound to the ING2 gene promoter to transcriptionally repress it. The siRNA knockdown of ING2 induced cellular senescence as effectively as Nutlin-3a treatment in human fibroblasts. While the Nutlin-3a-induced senescence was p53-dependent, the ING2 knockdown caused senescence even in the abscence of p53, suggesting that ING2 is a downstream effector of Nutlin-3a-induced, p53-mediated signaling to cellular senescence. Two different facets of the functional interplay between p53 and ING2 in the regulation of senescence are suggested by our studies: (a) the enhanced activity of ING2 induces senescence by post-translationally activating p53; and (b) the endogenous levels of ING2 restricts senescence under non-stressed conditions without p53 activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
p53, Aging, and Cancer
-
批准号:10486868
-
项目类别:
-
资助金额:$169.67万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Biomarkers of Human Lung Cancer
-
批准号:8552870
-
项目类别:
-
资助金额:$80.32万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53, Aging, and Cancer
-
批准号:9343959
-
项目类别:
-
资助金额:$152.73万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53, Aging, and Cancer
-
批准号:10702577
-
项目类别:
-
资助金额:$187.35万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53 Tumor Suppressor Pathway
-
批准号:8348895
-
项目类别:
-
资助金额:$64.42万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Human Colon Cancer
-
批准号:8349216
-
项目类别:
-
资助金额:$60.13万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome
-
批准号:10014704
-
项目类别:
-
资助金额:$114.78万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53, Aging, and Cancer
-
批准号:10262348
-
项目类别:
-
资助金额:$216.9万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Precision Medicine of Cancer
-
批准号:10262347
-
项目类别:
-
资助金额:$216.9万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Precision Medicine of Cancer
-
批准号:10486867
-
项目类别:
-
资助金额:$254.5万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53, Aging, and Cancer
-
批准号:8763568
-
项目类别:
-
资助金额:$80.22万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Biomarkers of Human Lung Cancer
-
批准号:8349212
-
项目类别:
-
资助金额:$60.13万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Human Colon Cancer
-
批准号:8552873
-
项目类别:
-
资助金额:$80.32万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Integrative Molecular Epidemiology of Human Cancer
-
批准号:9779934
-
项目类别:
-
资助金额:$171.19万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Precision Medicine of Cancer
-
批准号:10926229
-
项目类别:
-
资助金额:$257.01万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Integrative Molecular Epidemiology of Human Cancer
-
批准号:8938159
-
项目类别:
-
资助金额:$158.6万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Biomarkers of Human Esophageal Cancer
-
批准号:8157676
-
项目类别:
-
资助金额:$74.1万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Inflammation and Cancer
-
批准号:8157251
-
项目类别:
-
资助金额:$74.1万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Inhibitor of Normal Growth (ING)
-
批准号:8349213
-
项目类别:
-
资助金额:$60.13万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53 Tumor Suppressor Pathway
-
批准号:7965083
-
项目类别:
-
资助金额:$78.62万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: